Impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay.

<h4>Background</h4>Data on the burden of pneumococcal disease and the most frequent serotypes demonstrated that invasive disease and pneumonia were important manifestations affecting children under 5 years of age. Therefore, pneumococcal diseases prevention became a public health priorit...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	María Hortal, Miguel Estevan, Miguel Meny, Inés Iraola, Hilda Laurani
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2014
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/47fb8dafed1e4c4395be0da2758d27b1
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:47fb8dafed1e4c4395be0da2758d27b1
record_format	dspace
spelling	oai:doaj.org-article:47fb8dafed1e4c4395be0da2758d27b12021-11-18T08:16:42ZImpact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay.1932-620310.1371/journal.pone.0098567https://doaj.org/article/47fb8dafed1e4c4395be0da2758d27b12014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24905093/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Data on the burden of pneumococcal disease and the most frequent serotypes demonstrated that invasive disease and pneumonia were important manifestations affecting children under 5 years of age. Therefore, pneumococcal diseases prevention became a public health priority. Uruguay was the first Latin American country to incorporate PCV7 into its National Immunization Program. The aim of this study is to compare the incidence rates for hospitalized pneumonia in children from the pre PCV introduction period and the following five years of PCVs application in Uruguay.<h4>Methods and findings</h4>Population-based surveillance of pneumonia hospitalization rates, in children, less than 14 years of age, had been performed prior pneumococcal vaccination, and continued following PCV7 introduction and PCV13 replacement, using the same methodology. Hospitalized children with pneumonia were enrolled from January 1, 2009 through December 31st, 2012. The study was carried out in an area with a population of 238,002 inhabitants of whom 18, 055 were under five years of age. Patients with acute lower respiratory infections for whom a chest radiograph was performed on admission were eligible. Digitalized radiographs were interpreted by a reference radiologist, using WHO criteria. Pneumonia was confirmed in 2,697 patients, 1,267 with consolidated and 1,430 with non consolidated pneumonia of which incidence decrease, between 2009 and 2012, was 27.3% and 46.4% respectively. 2001-2004 and 2009-2012 comparison showed a significant difference of 20.4% for consolidated pneumonia hospitalizations. A significant incidence decline was recorded among children 6 to 35 months of age.<h4>Conclusions</h4>An overall significant reduction in pneumonia hospitalizations was observed following the introduction of PCV7 and furthermore following the change to PCV13.María HortalMiguel EstevanMiguel MenyInés IraolaHilda LauraniPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 6, p e98567 (2014)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q María Hortal Miguel Estevan Miguel Meny Inés Iraola Hilda Laurani Impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay.
description	<h4>Background</h4>Data on the burden of pneumococcal disease and the most frequent serotypes demonstrated that invasive disease and pneumonia were important manifestations affecting children under 5 years of age. Therefore, pneumococcal diseases prevention became a public health priority. Uruguay was the first Latin American country to incorporate PCV7 into its National Immunization Program. The aim of this study is to compare the incidence rates for hospitalized pneumonia in children from the pre PCV introduction period and the following five years of PCVs application in Uruguay.<h4>Methods and findings</h4>Population-based surveillance of pneumonia hospitalization rates, in children, less than 14 years of age, had been performed prior pneumococcal vaccination, and continued following PCV7 introduction and PCV13 replacement, using the same methodology. Hospitalized children with pneumonia were enrolled from January 1, 2009 through December 31st, 2012. The study was carried out in an area with a population of 238,002 inhabitants of whom 18, 055 were under five years of age. Patients with acute lower respiratory infections for whom a chest radiograph was performed on admission were eligible. Digitalized radiographs were interpreted by a reference radiologist, using WHO criteria. Pneumonia was confirmed in 2,697 patients, 1,267 with consolidated and 1,430 with non consolidated pneumonia of which incidence decrease, between 2009 and 2012, was 27.3% and 46.4% respectively. 2001-2004 and 2009-2012 comparison showed a significant difference of 20.4% for consolidated pneumonia hospitalizations. A significant incidence decline was recorded among children 6 to 35 months of age.<h4>Conclusions</h4>An overall significant reduction in pneumonia hospitalizations was observed following the introduction of PCV7 and furthermore following the change to PCV13.
format	article
author	María Hortal Miguel Estevan Miguel Meny Inés Iraola Hilda Laurani
author_facet	María Hortal Miguel Estevan Miguel Meny Inés Iraola Hilda Laurani
author_sort	María Hortal
title	Impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay.
title_short	Impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay.
title_full	Impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay.
title_fullStr	Impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay.
title_full_unstemmed	Impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay.
title_sort	impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in uruguay.
publisher	Public Library of Science (PLoS)
publishDate	2014
url	https://doaj.org/article/47fb8dafed1e4c4395be0da2758d27b1
work_keys_str_mv	AT mariahortal impactofpneumococcalconjugatevaccinesontheincidenceofpneumoniainhospitalizedchildrenafterfiveyearsofitsintroductioninuruguay AT miguelestevan impactofpneumococcalconjugatevaccinesontheincidenceofpneumoniainhospitalizedchildrenafterfiveyearsofitsintroductioninuruguay AT miguelmeny impactofpneumococcalconjugatevaccinesontheincidenceofpneumoniainhospitalizedchildrenafterfiveyearsofitsintroductioninuruguay AT inesiraola impactofpneumococcalconjugatevaccinesontheincidenceofpneumoniainhospitalizedchildrenafterfiveyearsofitsintroductioninuruguay AT hildalaurani impactofpneumococcalconjugatevaccinesontheincidenceofpneumoniainhospitalizedchildrenafterfiveyearsofitsintroductioninuruguay
_version_	1718421981442867200

Impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay.

Ejemplares similares